Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Approval save search
argenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thrombocytopenia
Published: 2024-03-26 (Crawled : 06:00) - globenewswire.com
ARGX | $360.11 0.47% 0.47% 330K
|
Health Technology
|
| O: 0.07%
H: 0.79%
C: -0.29%
japan vyvgart approval
Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension
Published: 2024-03-25 (Crawled : 23:00) - biospace.com/
AMRX | $5.42 1.12% 1.11% 1.1M
|
Health Technology
|
| O: 0.0%
H: 0.33%
C: -2.64%
fda approval
ATHA Energy Announces 92 Energy Obtains Shareholder Approval for Transaction
Published: 2024-03-25 (Crawled : 13:30) - globenewswire.com
NXE | $7.615 -0.33% -0.07% 4.2M
|
Non-Energy Minerals
|
| O: 0.65%
H: 2.05%
C: -2.18%
energy approval
Biosense Webster Submits Application to U.S. FDA Seeking Approval of the VARIPULSE™ Platform for the Treatment of Paroxysmal Atrial Fibrillation
Published: 2024-03-25 (Crawled : 12:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
fda approval treatment application platform
Peoples Financial Services Corp. and FNCB Bancorp, Inc. Announce Receipt of Shareholder Approval for Merger
Published: 2024-03-22 (Crawled : 21:00) - prnewswire.com
PFIS | $37.865 2.37% 2.31% 11K
|
Finance
| Email alert
Add to watchlist
FNCB | $5.33 -1.3% -1.31% 9.5K
|
Finance
| Email alert
Add to watchlist
services approval financial
U.S. Food and Drug Administration (FDA) Grants Full Approval for ELAHERE® (mirvetuximab soravtansine-gynx) for Certain Ovarian Cancer Patients
Published: 2024-03-22 (Crawled : 19:00) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
| Email alert
Add to watchlist
elahere drug approval food cancer grants
Ameren Missouri receives approval for largest-ever solar investment
Published: 2024-03-21 (Crawled : 21:00) - prnewswire.com
AEE | $73.88 1.89% 0.0% 1.3M
|
Utilities
|
| O: 0.93%
H: 0.0%
C: -1.09%
approval solar
Awiqli® (once-weekly basal insulin icodec) recommended for approval for the treatment of diabetes by the European regulatory authorities
Published: 2024-03-21 (Crawled : 16:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.04%
H: 1.6%
C: 0.64%
awiqli approval treatment diabetes insulin
Idorsia Wins FDA Approval in Hypertension Months After J&J Returned Rights to Drug
Published: 2024-03-21 (Crawled : 12:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
fda drug approval hypertension
Idorsia Wins FDA Approval in Hypertension Months After J&J Returned Rights to...
Published: 2024-03-21 (Crawled : 12:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
fda approval hypertension
Breeze Holdings Acquisition Corp. Announces Nasdaq Panel Approval for Continued Listing to Complete Initial Business Combination by May 28, 2024
Published: 2024-03-20 (Crawled : 21:00) - globenewswire.com
BREZ | $11.4914 -2.02% 6K
|
|
| O: 0.51%
H: 0.0%
C: -0.51%
nasdaq business approval acquisition
Scilex Holding Company Announces Seeking Approval from the FDA for Modification of the Gloperba® Label to Provide Specific Dosing Guidance for Patients with Renal Impairment and Other Circumstances Where Dose Adjustment is Needed
Published: 2024-03-20 (Crawled : 15:00) - globenewswire.com
SCLX | $0.8812 -2.09% -2.13% 2.1M
|
|
| O: 0.0%
H: 3.7%
C: 0.74%
gloperba fda label company renal approval
Fusion Fuel Receives Provisional Grant Approval for 25 MW HEVO-Aveiro Green Hydrogen Project
Published: 2024-03-20 (Crawled : 09:00) - globenewswire.com
HTOO | $1.28 -2.29% -2.34% 52K
|
|
| O: 0.0%
H: 15.0%
C: 11.87%
approval grant hydrogen
Feutune Light Acquisition Corporation Announces Stockholder Approval for Extending Business Combination Deadline and Merger Agreement Amendment with Thunder Power Holdings Limited
Published: 2024-03-20 (Crawled : 03:00) - globenewswire.com
FLFV | $10.92 0.82% 630
|
n/a
|
| O: -100.0%
H: NaN%
C: Infinity%
business approval corporation light deadline acquisition agreement
Takeda Announces U.S. FDA Approval of Supplemental New Drug Application (sNDA) for ICLUSIG® (ponatinib) in Adult Patients with Newly Diagnosed Ph+ ALL
Published: 2024-03-19 (Crawled : 17:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: -0.96%
iclusig fda drug takeda approval application
Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in China
Published: 2024-03-19 (Crawled : 12:00) - globenewswire.com
CMND | $1.22 3.56% 3.43% 110K
|
n/a
|
| O: 1.54%
H: 1.52%
C: -2.27%
patent granted approval treatment china
Orchard Therapeutics Receives FDA Approval of Lenmeldy™ (atidarsagene autotemcel), the Only Therapy for Eligible Children with Early-onset Metachromatic Leukodystrophy in the U.S.
Published: 2024-03-18 (Crawled : 20:00) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
| Email alert
Add to watchlist
fda children approval therapeutics therapy
Azul TecOps Gains EASA Approval for Maintenance Services of European Union-Registered Aircraft
Published: 2024-03-18 (Crawled : 17:00) - prnewswire.com
AZUL | $5.78 -0.35% 0.0% 2.1M
|
Transportation
|
| O: 0.13%
H: 2.11%
C: 1.5%
services approval
Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB®
Published: 2024-03-18 (Crawled : 14:00) - biospace.com/
SCLX | $0.8812 -2.09% -2.13% 2.1M
|
|
| O: -0.73%
H: 3.31%
C: 0.74%
elyxyb drug patent company health approval review canada submission
Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura in Canada
Published: 2024-03-18 (Crawled : 13:00) - globenewswire.com
SCLX | $0.8812 -2.09% -2.13% 2.1M
|
|
| O: -0.73%
H: 3.31%
C: 0.74%
elyxyb drug patent company health approval review treatment canada migraine submission
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.